Jeanne Chiaravalli

SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution

Jiří Zahradník, Shir Marciano, Maya Shemesh et al. · Nature Microbiology · 2021 · 421 citations · Full text

Life Sciences, Bioinformatics, Infectious Diseases +9

NEMO specifically recognizes K63‐linked poly‐ubiquitin chains through a new bipartite ubiquitin‐binding domain

Emmanuel Laplantine, E Fontan, Jeanne Chiaravalli et al. · The EMBO Journal · 2009 · 196 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +9

Small-molecule inhibition of Lats kinases may promote Yap-dependent proliferation in postmitotic mammalian tissues

Nathaniel R. Kastan, Ksenia Gnedeva, Theresa Alisch et al. · Nature Communications · 2021 · 188 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +14

Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential

Bjoern Meyer, Jeanne Chiaravalli, Stacy Gellenoncourt et al. · Nature Communications · 2021 · 132 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

SARS-CoV-2 RBD <i>in vitro</i> evolution follows contagious mutation spread, yet generates an able infection inhibitor

Jiří Zahradník, Shir Marciano, Maya Shemesh et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2021 · 116 citations · Full text

Life Sciences, Infectious Diseases, Molecular Evolution +13